Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice

British Journal of Haematology

Volumn 96, Issue 4, 1997, Pages 757-761

  Zeis, M ^a   Uharek, L ^a   Glass, B ^a   Steinmann, J ^a   Dreger, P ^a   Gassmann, W ^a   Schmitz, N ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

allogeneic BMT; GVHD; GVL; immunotherapy; NK cells

Indexed keywords

INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CONTROLLED STUDY; GRAFT VERSUS LEUKEMIA EFFECT; LEUKEMIA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0031052699     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.d01-2101.x     Document Type: Article

References (19)

1. Antin, J.H. (1993) Graft-versus-leukemia effect: no longer an epiphenomenon. Blood, 82, 2273-2277.
2. Glass, B., Uharek, L., Gassmann, W., Focks, B., Bolouri, H. & Loeffler, H. (1992) Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease. Annals of Hematology, 64, 255-259.
3. Glass, B., Uharek, L., Zeis, M., Loeffler, H., Mueller-Ruchholtz, W. & Gassmann, W. (1996) Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells. British Journal of Haematology, 93, 412-420.
4. Gumperz, J.E. & Parham, P. (1995) The enigma of the natural killer cell. Nature. 378, 245-248.
5. Hauch, M., Gazzola, M.V., Small, T., Bordignon, C., Barnett, L., Cunningham, I., Castro, Malaspinia, H., O'Reilly, R.J. & Keever, C.A. (1990) Anti-leukaemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. Blood, 75, 2250-2262.
6. Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.-J., Rimm, A.A., Ringdén, O., Rozman, C., Speck, B., Truitt, R.L., Zwaan, F.E. & Bortin, M.M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555-562.
7. Jiang, Y.Z., Cullis, J.O., Kanfer, E.J., Goldman, J.M. & Barrett, A.J. (1993) T cell and NK cell mediated graft-versus-leukemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplantation, 11, 133-138.
8. Johnson, B.D. & Truitt, R.L. (1995) Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance and allows for persistent antileukemic reactivity without severe graft-versus-host disease. Blood, 85, 3302-3312.
9. Kim, K.J., Kannelopoulus-Langevin, C., Mervin, R.M., Sachs, D.H. & Asofsky, R. (1979) Establishment and characterization of Balb/c lymphoma lines with B cell properties. Journal of Immunology, 122, 549-554.
10. Kolb, H.J., Mittermuller, J. & Clemm, C. (1990) Donor leucocyte transfusion for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood, 76, 2462-2465.
11. O'Kunewick, J.P., Kociban, D.L., Machen, L.L., Buffo, M.J. (1995) Evidence for a possible role of asialo-GM1-positive cells in the graft-versus-leukemia repression of a murine type-C retroviral leukemia. Bone Marrow Transplantation, 16, 451-456.
12. Porter, D.L., Mark, S.R., McGarigle, C., Ferrara, J.LM. & Antin, J.H. (1994) Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. New England Journal of Medicine, 330, 100-106.
13. Szer, J., Grigg, A.P., Phillips, G.L. & Sheridan, W.P. (1993) Donor leukocyte infusions after chemotherapy for patients relapsing with acute leukemia following allogeneic BMT. Bone Marrow Transplantation, 11, 109-114.
14. Truitt, R.L., Shih, C.C.Y. & LeFever, A.V. (1986) Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma. Transplantation, 41, 301-310.
15. Uharek, L., Glass, B., Gaska, T., Zeis, M., Gassmann, W., Loeffler, H. & Mueller-Ruchholtz, W. (1993) Natural killer cells as effector cells of graft-versus-leukemia activity in a murine transplantation model. Bone Marrow Transplantation, 12, (Suppl. 3), 57-60.
16. Xun, C.Q., Thompson, J.S., Jennings, C.D. & Brown, S.A. (1995) The effect of human IL-2-activated natural killer and T cells on graftversus-hosst disease and graft-versus-leukemia in SCID mice bearing human leukemic cells. Transplantation, 60, 821-827.
17. Yokoyama, W.M. & Seaman, W.E. (1993) The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annual Reviews of Immunology, 11, 613-635.
18. Zeis, M., Uharek, L., Glass, B., Gaska, T., Gassmann, W., Löffler, H. & Mueller-Ruchholtz, W. (1995) Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation. Transplantation, 59, 1734-1736.
19. Zeis, M., Uharek, L., Glass, B., Gaska, T., Gassmann, W. & Mueller-Ruchholtz, W. (1994) Induction of graft-versus-leukemia activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts. Bone Marrow Transplantation, 14, 711-715.